Navigation Links
Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success
Date:7/30/2008

accurate and precise test to monitor patients on low-dose treatment regimens. "At low doses, even the slightest variation in blood-level readings could be devastating to transplant patients. The consequence for the laboratory is twofold: it must have accurate, precise testing for immunosuppressive drugs, and tacrolimus tests that are accurate to 4 ng/mL are no longer adequate," he explained.

Dr. Levine reported results of his studies evaluating the performance of the Abbott ARCHITECT assay for tacrolimus, the most widely used immunosuppressant drug. He said the usual dosing range for the medication is between 2 and 15 ng/mL, with lower doses preferred. "The challenge for the laboratory, therefore, is to assure with the utmost confidence to the physician that a tacrolimus blood level of 3 ng/mL is exactly right and not 5," Levine said.

In the trials, the Abbott ARCHITECT tacrolimus assay was accurate and precise at low levels and showed consistent results. "The functional sensitivity in our hands was 0.9 ng/mL, exceeding the package insert claim of 2 ng/mL. We are fully confident the ARCHITECT tacrolimus assay meets our requirement for low-level tacrolimus monitoring," Levine said.

"The ARCHITECT tacrolimus assay is the only automated transplant monitoring test that meets international standards for low-level monitoring," according to Dr. Hebbar.

The ARCHITECT tacrolimus assay is used for the quantitative determination of tacrolimus in human whole blood, as an aid in managing liver and kidney transplant patients receiving tacrolimus therapy.

About the ARCHITECT Family

With its extensive menu of diagnostic tests, user-friendly software and advanced sample management capabilities, the ARCHITECT family and the currently marketed flagship analyzer, ARCHITECT(R) ci8200(R), meet the needs of today's diagnostics laboratory by enhancing workflow and productivity. ARCHITECT instruments are designed with laboratory-focused features su
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained With Naproxen Sodium
2. Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study
3. Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
4. Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
5. Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
6. eRT Announces the Availability of the Suicidality Monitoring System(TM) For Clinical Trials
7. University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients
8. Independent Studies Report on Possible Roles for Cylexs Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients
9. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
10. Medicare Announces Expanded Coverage for Warfarin Patients Monitoring Clotting Time at Home
11. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 27, 2015 Research and Markets ( ... "Global Neurostimulation Devices Market 2015" report ... the global neurostimulation devices market to grow at ... The report, Global Neurostimulation Devices Market ... market analysis with inputs from industry experts. The ...
(Date:7/29/2015)... a privately-held regenerative medicine company with the first stem cell-derived islet ... announced the opening of a second site in its Phase 1/2 ... and E fficacy of VC-01™ Combination P roduct in ... first in Canada , will be at the ... The lead Edmonton investigator ...
(Date:7/29/2015)... , July 29, 2015  Fifty groups representing ... Wednesday, July 29, to launch the AllTrials campaign in ... trial, past, present, and future, to be registered and ... co-founder Dr Ben Goldacre explains: "Patients want ... good quality evidence on what works. Unfortunately, we now ...
Breaking Medicine Technology:Global Neurostimulation Devices Market 2015-2019 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 3ViaCyte Announces Second Clinical Trial Site at University of Alberta 4Fixing Your Medicine: AllTrials Campaign Launches in US 2Fixing Your Medicine: AllTrials Campaign Launches in US 3
... Data published in BMC Cancer and PLoS ... highly differentiated diagnosis from blood samples for lung cancer and ... patient tissue samples may become obsolete in the coming years. ... at the University of Saarland (Germany) investigated the performance of ...
... , DALLAS, Oct. 13 Eclipsemed Ltd, a leading ... announced its recent partnership with Human Med USA. ... medical and aesthetic devices including the revolutionary Body-Jet®, has ... increase efforts to sell Body-Jet® in the United States ...
Cached Medicine Technology:MicroRNA Biomarkers Provide Reliable Diagnosis from Blood Samples 2Eclipse Announces Partnership with Human Med USA, Manufacturers of Revolutionary Body-Jet(R) 2
(Date:7/29/2015)... New York, NY (PRWEB) , ... July 29, 2015 , ... ... Petitions were approved by USCIS over the past month! I-829 approvals have been granted ... projects in Los Angeles, the Kimpton Lafayette Hotel project in Philadelphia, and the ...
(Date:7/29/2015)... ... July 29, 2015 , ... Inspired ... Foundation in March, Steven W. Meier M.D., a prominent orthopedic surgeon and regenerative ... patients with demonstrated financial need. , “We are thrilled for this opportunity to ...
(Date:7/29/2015)... ... July 29, 2015 , ... Employee Fiduciary, LLC announces ... the general contact information, website, types of plans administered, years in business, and credentials ... and have at least one plan with Employee Fiduciary. A search can be done ...
(Date:7/29/2015)... ... ... TransFlip is an all new dynamic transition pack for FCPX, containing flipping ... are easy to apply and modify for any skill-level user. TransFlip includes custom bounce ... kinetic flipping panel animations are just a few clicks away. , TransFlip contains over ...
(Date:7/29/2015)... ... July 29, 2015 , ... Toronto native ... late 1970s, Dr. Cottrell has been making predictions about the economy, politics, social ... many of these prognostications. He warns that extreme weather conditions and increased earthquake ...
Breaking Medicine News(10 mins):Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 3Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2Health News:Employee Fiduciary Launches Financial Advisor Directory 2Health News:Pixel Film Studios Releases FCPX Transition TransFlip for FCPX 2Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2
... have discovered that activation of a particular brain region ... The results of this Duke University Medical Center study ... of Nature Neuroscience. ,"Although understanding the ... what drives people like Mother Theresa, it may give ...
... growing number of youngsters are contracting tuberculosis, especially those in ... excessive weight loss, according to a report. ... in their 20s. ,According to the report ... people contracted tuberculosis in 2006, an average of 115 people ...
... how beneficial traits shape up in natural populations,// but one ... costly traits. Two theories have tried to address this challenge ... selection. ,The theory of hitchhiking has indicated ... become frequent in natural populations when they "hitch a ride" ...
... that has left its victims stoned. , Federal agents ... producing establishments Wednesday. The raids are the biggest raids to ... than 5000 pounds of pot (marijuana), as well as pot-laced ... According to the pot retailers, which include marijuana medical clinic ...
... research that does not bark up the wrong tree. ,According to ... //evidence to back the fact that owning a dog is indeed ... in lower blood pressure and cholesterol, it reduces the occurrence of ... problems. This could be attributed to the positive impact of owning ...
... Novartis bagged the contract to make a chemical that ... million contract// was finalised on Wednesday. ,The ... contracts to fight a possible bird-flu outbreak in humans. ... on Wednesday by the U.S. Department of Health and ...
Cached Medicine News:Health News:Activation of a Particular Brain Region Predicts Altruism: Study 2Health News:More Youngsters Get Tuberculosis 2Health News:The Evolution of Costly Traits 2
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
Medicine Products: